【ChiCTR1900025199】Changes in HOMA-IR Index Levels After Bariatric Surgery: Comparison of Single Anastomosis Duodenal Switch (SADS) and One Anastomosis Gastric Bypass (OAGB-MGB)
ChiCTR1900025199
结束
/
/
/
2019-08-16
/
/
肥胖
Changes in HOMA-IR Index Levels After Bariatric Surgery: Comparison of Single Anastomosis Duodenal Switch (SADS) and One Anastomosis Gastric Bypass (OAGB-MGB)
Changes in HOMA-IR Index Levels After Bariatric Surgery: Comparison of Single Anastomosis Duodenal Switch (SADS) and One Anastomosis Gastric Bypass (OAGB-MGB)
06830
Bariatric surgery plays a major role in ameliorating metabolic abnormalities of type 2 diabetes (T2DM). The aim of this study was to evaluate the early effects of “Single Anastomosis Duodenal Switch-proximal approach” (SADS-p) and “One Anastomosis Gastric Bypass-Mini Gastric Bypass (OAGB-MGB) on the “homeostasis model assessment of insulin resistance” (HOMA-IR) index levels in morbidly obese patients with T2DM.
连续入组
回顾性研究
N/A
N/A
own funding
/
260
/
2017-05-29
2018-07-16
/
The study was performed according to the principles of the Helsinki Declaration. Ethics Committee of Ankara Liv Hospital approved the study. In this retrospective, parallel group trial, all patients were evaluated for bariatric surgery by a multidisciplinary team of a surgeon, an endocrinologist, a psychologist, dietitian and an anesthesiologist. Two hundred and sixty morbidly obese patients (Body Mass Index>40kg/m2 or Body Mass Index>35kg/m2 + two co-morbidities) who underwent OAGB-MGB (n=200) and SADS-p (n=60) were included in the study. Patients requiring revisional surgery were excluded from the study. Both surgical techniques were described in detail to the patients. Surgical technique was selected considering the presence of T2DM, body mass index (BMI), eating habits, and requests of the patients. Fasting insulin (FI), fasting blood glucose (FBG), HbA1c, “homeostasis model assessment of insulin resistance” (HOMA-IR index), excess weight loss (EWL), and BMI, body weight were collected before surgery and at 1, 3, 9, 12 months after surgery. HOMA-IR index was calculated from FBG and FI levels.；
请登录查看explained above.；
请登录查看土耳其安卡拉伊斯坦尼医科大学
06830
土耳其安卡拉伊斯坦尼医科大学的其他临床试验
土耳其安卡拉伊斯坦尼医科大学的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构：国家药品监督管理局 2026-09-10
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-09-28
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构：国家市场监督管理总局 2026-09-18
-
颁布机构：国家市场监督管理总局 2026-09-17
-
颁布机构：国家市场监督管理总局 2026-08-10